Griseofulvin microbiology

Griseofulvin
Grifulvin V®,GRIS-PEG® Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Microbiology

GRIFULVIN V® (griseofulvin tablets) microsize inhibits the growth of those genera of fungi that commonly cause ringworm infections of the hair, skin, and nails, such as:

• Trichophyton rubrum

• Trichophyton tonsurans

• Trichophyton mentagrophytes

• Trichophyton interdigitalis

• Trichophyton verrucosum

• Trichophyton sulphureum

• Trichophyton schoenleini

• Microsporum audouini

• Microsporum canis

• Microsporum gypseum

• Epidermophyton floccosum

• Trichophyton megnini

• Trichophyton gallinae

• Trichophyton crateriform

Note: Prior to therapy, the type of fungi responsible for the infection should be identified. The use of the drug is not justified in minor or trivial infections which will respond to topical antifungal agents alone.

GRIS-PEG® ultramicrosize is fungistatic with in vitro activity against various species of Microsporum, Epidermophyton and Trichophyton. It has no effect on bacteria or other genera of fungi

References

Adapted from the FDA Package Insert.